Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Neuroinflammation ; 7: 42, 2010 Jul 30.
Article in English | MEDLINE | ID: mdl-20673332

ABSTRACT

BACKGROUND: The enzyme cytosolic phospholipase A2 alpha (cPLA2alpha) has been implicated in the progression of cerebral injury following ischemia and reperfusion. Previous studies in rodents suggest that cPLA2alpha enhances delayed injury extension and disruption of the blood brain barrier many hours after reperfusion. In this study we investigated the role of cPLA2alpha in early ischemic cerebral injury. METHODS: Middle cerebral artery occlusion (MCAO) was performed on cPLA2alpha+/+ and cPLA2alpha-/- mice for 2 hours followed by 0, 2, or 6 hours of reperfusion. The levels of cPLA2alpha, cyclooxygenase-2, neuronal morphology and reactive oxygen species in the ischemic and contralateral hemispheres were evaluated by light and fluorescent microscopy. PGE2 content was compared between genotypes and hemispheres after MCAO and MCAO and 6 hours reperfusion. Regional cerebral blood flow was measured during MCAO and phosphorylation of relevant MAPKs in brain protein homogenates was measured by Western analysis after 6 hours of reperfusion. RESULTS: Neuronal cPLA2alpha protein increased by 2-fold immediately after MCAO and returned to pre-MCAO levels after 2 hours reperfusion. Neuronal cyclooxygenase-2 induction and PGE2 concentration were greater in cPLA2alpha+/+ compared to cPLA2alpha-/- ischemic cortex. Neuronal swelling in ischemic regions was significantly greater in the cPLA2alpha+/+ than in cPLA2alpha-/- brains (+/+:2.2+/-0.3 fold vs. -/-:1.7+/-0.4 fold increase; P<0.01). The increase in reactive oxygen species following 2 hours of ischemia was also significantly greater in the cPLA2alpha+/+ ischemic core than in cPLA2alpha-/- (+/+:7.12+/-1.2 fold vs. -/-:3.1+/-1.4 fold; P<0.01). After 6 hours of reperfusion ischemic cortex of cPLA2alpha+/+, but not cPLA2alpha-/-, had disruption of neuron morphology and decreased PGE2 content. Phosphorylation of the MAPKs-p38, ERK 1/2, and MEK 1/2-was significantly greater in cPLA2a+/+ than in cPLA2alpha-/- ischemic cortex 6 hours after reperfusion. CONCLUSIONS: These results indicate that cPLA2alpha modulates the earliest molecular and injury responses after cerebral ischemia and have implications for the potential clinical use of cPLA2alpha inhibitors.


Subject(s)
Brain Ischemia/physiopathology , Cyclooxygenase 2/metabolism , Group IV Phospholipases A2/metabolism , Mitogen-Activated Protein Kinases/metabolism , Oxidative Stress , Reperfusion Injury/physiopathology , Animals , Brain Ischemia/metabolism , Dinoprostone/metabolism , Female , Group IV Phospholipases A2/genetics , Infarction, Middle Cerebral Artery/physiopathology , Male , Mice , Mice, Knockout , Neurons/cytology , Neurons/metabolism , Phosphorylation
2.
Article in English | MEDLINE | ID: mdl-20486873

ABSTRACT

The effect of transfusion of PEGylated hemoglobin (PEG-Hb) was evaluated in anesthetized rats subjected to 2 hours of focal cerebral ischemia and 1 day of reperfusion. PEG-Hb was stored in the carboxy state (PEG-COHb) to reduce autooxidation and increase the shelf life. Transfusion of 10 ml/kg of PEG-COHb at 20 minutes of ischemia did not alter arterial blood pressure or increase red cell flux in the ischemic core. Plasma hemoglobin increased to only 0.6 g/dL, yet infarct volume was markedly decreased and neurological deficits were improved. We conclude that early topload transfusion of PEG-COHb protects the brain from ischemic stroke.


Subject(s)
Blood Transfusion/methods , Carboxyhemoglobin/chemistry , Carboxyhemoglobin/therapeutic use , Ischemic Attack, Transient/therapy , Polyethylene Glycols/chemistry , Animals , Blood Gas Analysis , Blood Pressure , Body Temperature , Cattle , Electrolytes/blood , Ischemic Attack, Transient/blood , Ischemic Attack, Transient/physiopathology , Male , Rats , Rats, Wistar , Time Factors
3.
J Neurochem ; 113(4): 1012-22, 2010 May.
Article in English | MEDLINE | ID: mdl-20236222

ABSTRACT

Excessive oxidative damage to DNA leads to activation of poly(ADP-ribose) polymerase-1 (PARP-1), accumulation of PAR polymers, translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus, and cell death. In this study, we compared the effect of gene deletion of PARP-1 and PARP-2, enzymes activated by DNA oxidative damage, in male mice subjected to 2 h of focal cerebral ischemia. Infarct volume at 3 days of reperfusion was markedly decreased to a similar extent in PARP-1- and PARP-2-null mice. The ischemia-induced increase in nuclear AIF accumulation was largely suppressed in both knockout genotypes. The transient increase in PAR during early reperfusion was nearly blocked in PARP-1-null mice, but only moderately decreased at 1-h reperfusion in PARP-2-null mice. Differences in the tissue volume at risk, as assessed by arterial casts and autoradiographic analysis of regional blood flow, did not fully account for the large reductions in AIF translocation and infarct volume in both PARP null mice. Cell death was attenuated in PARP-2-null neurons exposed to a submaximal concentration of 100 microM NMDA for 5 min, but not in those exposed to a near-maximal toxic concentration of 500 microM NMDA. We conclude that PARP-2 contributes substantially to nuclear translocation of AIF and infarct size after transient focal cerebral ischemia in male mice, but that protection is disproportionate to the attenuation of overall PARP activity.


Subject(s)
Active Transport, Cell Nucleus/physiology , Apoptosis Inducing Factor/metabolism , Brain Ischemia/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Animals , Apoptosis Inducing Factor/genetics , Brain/metabolism , Brain/physiopathology , Brain Ischemia/genetics , Brain Ischemia/physiopathology , Cell Nucleus/metabolism , Cells, Cultured , Disease Models, Animal , Dose-Response Relationship, Drug , Excitatory Amino Acid Agonists/toxicity , Glutamic Acid/metabolism , Glutamic Acid/toxicity , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Degeneration/genetics , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Neurons/metabolism , Oxidative Stress/drug effects , Oxidative Stress/physiology , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/genetics , Reperfusion Injury/genetics , Reperfusion Injury/metabolism , Reperfusion Injury/physiopathology
4.
J Cereb Blood Flow Metab ; 29(3): 629-39, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19107134

ABSTRACT

This study examined the effects of an inhibitor of 20-hydroxyeicosatetraenoic acid (20-HETE) synthesis, N-(3-chloro-4-morpholin-4-yl)phenyl-N'-hydroxyimido formamide (TS-011), on infarct volume, volume at risk, cerebral blood flow (CBF), and levels of cytochrome P450 (CYP450) eicosanoids in the brain after transient occlusion of the middle cerebral artery (t-MCAO) in rats. TS-011 (0.1 mg/kg, iv) reduced cortical infarct volume by approximately 70% and total infarct volume by 55%. TS-011 had no effect on the volume at risk or CBF during or up to 30 mins after the ischemic period. TS-011 reduced the delayed fall in CBF seen 2 h after reperfusion. The levels of CYP450 eicosanoids were similar in the ischemic and contralateral hemispheres after t-MCAO. TS-011 reduced 20-HETE levels in cerebral tissue by 80% but had no effect on the levels of EETs. Administration of another 20-HETE inhibitor, HET0016 (0.01 to 1.0 mg/kg, iv) or a 20-HETE antagonist 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (10 mg/kg, iv) also reduced infarct size. These results indicate that inhibitors of the synthesis or vasoconstrictor effects of 20-HETE reduce infarct size in rats after cerebral ischemia. The effects of TS-011 are not associated with changes in the area at risk or CBF and may be because of a potential protective effect in neurons subjected to ischemic stress.


Subject(s)
Cerebrovascular Circulation/drug effects , Formamides/therapeutic use , Hydroxyeicosatetraenoic Acids/antagonists & inhibitors , Infarction, Middle Cerebral Artery/prevention & control , Morpholines/therapeutic use , Neuroprotective Agents/therapeutic use , Animals , Brain/drug effects , Brain/enzymology , Brain/metabolism , Brain/pathology , Chromatography, High Pressure Liquid , Cytochrome P-450 Enzyme System/metabolism , Disease Models, Animal , Formamides/pharmacology , Infarction, Middle Cerebral Artery/metabolism , Infarction, Middle Cerebral Artery/pathology , Infarction, Middle Cerebral Artery/physiopathology , Laser-Doppler Flowmetry , Male , Mass Spectrometry , Morpholines/pharmacology , Neuroprotective Agents/pharmacology , Rats , Rats, Wistar
5.
Stroke ; 39(3): 967-74, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18239169

ABSTRACT

BACKGROUND AND PURPOSE: Transient ischemic attacks have long been regarded as a risk factor for the incidence of stroke but may reduce the severity of stroke by inducing ischemic tolerance. The present objective was to develop an ischemic preconditioning (IPC) model of delayed tolerance in the mouse based on repetitive, transient middle cerebral artery occlusion (MCAO). METHODS: Mice anesthetized with halothane or isoflurane underwent IPC, which consisted of repetitive MCAO at 45-minute intervals by the intraluminal filament technique. A 90-minute test MCAO was performed 24 to 96 hours later. RESULTS: Using an IPC of 2 5-minute MCAO episodes, the reduction in infarct volume from the test MCAO was maximal with a 72-hour delay in striatum (70%) and cerebral cortex (64%) when halothane was used for surgical anesthesia. With isoflurane anesthesia, the reduction in infarct volume was less prominent in striatum (34%) and not significant in cortex (9%) despite similar levels of arterial pressure and decreases in cortical perfusion. Neuronal cell death was rare 6 days after this IPC stimulus alone with halothane or isoflurane. Increasing the severity of IPC to 3 5-minute bouts or 1 15-minute bout of MCAO in the presence of isoflurane anesthesia augmented the reduction in infarct volume in striatum and cortex, but it also augmented selective neuronal cell death in striatum after the IPC stimulus alone. CONCLUSIONS: These data demonstrate that a repetitive focal IPC stimulus can be titrated to induce delayed tolerance in both striatum and cortex of the mouse without inducing neuronal death by itself.


Subject(s)
Brain/pathology , Brain/physiopathology , Disease Models, Animal , Infarction, Middle Cerebral Artery/pathology , Infarction, Middle Cerebral Artery/physiopathology , Ischemic Preconditioning/methods , Anesthesia , Anesthetics, Inhalation , Animals , Cell Survival , Cerebral Cortex/blood supply , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Corpus Striatum/pathology , Corpus Striatum/physiopathology , Halothane , Isoflurane , Male , Mice , Mice, Inbred C57BL , Neurons/pathology , Regional Blood Flow , Time Factors
6.
Proc Natl Acad Sci U S A ; 103(48): 18308-13, 2006 Nov 28.
Article in English | MEDLINE | ID: mdl-17116882

ABSTRACT

Excessive activation of the nuclear enzyme, poly(ADP-ribose) polymerase-1 (PARP-1) plays a prominent role in various of models of cellular injury. Here, we identify poly(ADP-ribose) (PAR) polymer, a product of PARP-1 activity, as a previously uncharacterized cell death signal. PAR polymer is directly toxic to neurons, and degradation of PAR polymer by poly(ADP-ribose) glycohydrolase (PARG) or phosphodiesterase 1 prevents PAR polymer-induced cell death. PARP-1-dependent, NMDA excitotoxicity of cortical neurons is reduced by neutralizing antibodies to PAR and by overexpression of PARG. Neuronal cultures with reduced levels of PARG are more sensitive to NMDA excitotoxicity than WT cultures. Transgenic mice overexpressing PARG have significantly reduced infarct volumes after focal ischemia. Conversely, mice with reduced levels of PARG have significantly increased infarct volumes after focal ischemia compared with WT littermate controls. These results reveal PAR polymer as a signaling molecule that induces cell death and suggests that interference with PAR polymer signaling may offer innovative therapeutic approaches for the treatment of cellular injury.


Subject(s)
Apoptosis/drug effects , Poly Adenosine Diphosphate Ribose/toxicity , Polymers/toxicity , Signal Transduction , Animals , Caspases/metabolism , Cells, Cultured , Mice , Molecular Weight , Neurons/drug effects , Poly Adenosine Diphosphate Ribose/chemistry , Poly(ADP-ribose) Polymerases/metabolism , Polymers/chemistry
7.
Magn Reson Med ; 51(5): 945-52, 2004 May.
Article in English | MEDLINE | ID: mdl-15122676

ABSTRACT

The proton exchange processes between water and solutes containing exchangeable protons have recently become of interest for monitoring pH effects, detecting cellular mobile proteins and peptides, and enhancing the detection sensitivity of various low-concentration endogenous and exogenous species. In this work, the analytic expressions for water exchange (WEX) filter spectroscopy, chemical exchange-dependent saturation transfer (CEST), and amide proton transfer (APT) experiments are derived by the use of Bloch equations with exchange terms. The effects of the initial states for the system, the difference between a steady state and a saturation state, and the relative contributions of the forward and backward exchange processes are discussed. The theory, in combination with numerical calculations, provides a useful tool for designing experimental schemes and assessing magnetization transfer (MT) processes between water protons and solvent-exchangeable protons. As an example, the case of endogenous amide proton exchange in the rat brain at 4.7 T is analyzed in detail.


Subject(s)
Magnetic Resonance Imaging , Animals , Brain , Ion Exchange , Models, Theoretical , Protons , Rats
8.
Contemp Top Lab Anim Sci ; 41(6): 9-14, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12456152

ABSTRACT

Appropriate and efficacious use of analgesics in rodents must be balanced judiciously between animal needs and research objectives. A concern in many studies is that analgesia will confound experimental outcome or interpretation. Accordingly, determining whether rats subjected to surgical protocols show evidence of pain is important if we are to provide rational postoperative analgesia without compromising experimental objectives. The goal of this study was to evaluate both subjective and objective measures for pain evaluation in male Wistar rats subjected to sham middle cerebral artery occlusion (MCAO) surgery and to determine whether buprenorphine would be an appropriate analgesic in this surgical model. Male Wistar rats underwent a sham 2-h MCAO by the intraluminal filament technique followed by 22-h of recovery. Animals were randomly assigned to one of three postoperative treatment groups: vehicle only (VH; vehicle subcutaneously [s.c.] + plain jello orally), low-dose buprenorphine (LB; 0.05 mg/kg s.c. _ 0.25 mg/kg drug-in-jello orally), and high-dose buprenorphine (HB; 0.5 mg/kg s.c. + 0.25 mg/kg drug-in-jello orally). Animals received subcutaneous treatments prior to anesthetic recovery and approximately 18-h later. Jello treatments were given once at the end of the surgery day. We modified a previously published behavioral scoring system which is based on subjective and objective measures for pain evaluation. All animals were evaluated for pain before sham surgery (baseline) and at 3-, 18-, and 22-h postoperatively by observers who were blinded to treatment group. Brains were removed at 22-h after surgery and evaluated by 2,3,5-triphenyltetrazolium chloride staining to confirm lack of brain injury from the sham procedure. Sham intraoperative physiological variables were equivalent among treatment groups. Baseline assessment scores were zero for all groups. Postoperatively, all treatment groups showed elevated assessment scores relative to baseline values. Buprenorphine at the tested doses did not markedly reduce total assessment scores postoperatively relative to those in vehicle-treated animals. Further evaluation of rodent postoperative pain and response to analgesia is needed if we are to formulate a sound scientific approach to animal management in protocols requiring surgical manipulations.


Subject(s)
Analgesia/veterinary , Analgesics, Opioid , Buprenorphine , Minor Surgical Procedures/veterinary , Pain, Postoperative/veterinary , Rats, Wistar/physiology , Administration, Oral , Analgesia/methods , Animals , Cerebral Arteries/surgery , Dose-Response Relationship, Drug , Male , Minor Surgical Procedures/adverse effects , Pain Measurement/drug effects , Pain, Postoperative/physiopathology , Pain, Postoperative/prevention & control , Rats , Rats, Wistar/surgery , Single-Blind Method
SELECTION OF CITATIONS
SEARCH DETAIL
...